Changes in the gene expression of GABAA receptor α1 and α2 subunits and metabotropic glutamate receptor 5 in the basal ganglia of the rats with unilateral 6-hydroxydopamine lesion and embryonic mesencephalic grafts

Experimental Neurology

Volumn 168, Issue 2, 2001, Pages 231-241

  Yu, Tzong Shiue ^a   Wang, Shwun De ^b   Liu, Jiang Chuan ^b   Yin, Hsiang Shu ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

GABAA receptor binding autoradiography; In situ hybridization; Nonisotopic oligonucleotide probe; Parkinson's disease; Plasticity; Transplantation

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; FLUNITRAZEPAM; GLUTAMATE RECEPTOR 5; OXIDOPAMINE; PROTEIN SUBUNIT; TRITIUM; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BASAL GANGLION; BRAIN INJURY; BRAIN TRANSPLANTATION; CONTROLLED STUDY; EMBRYO; GENE EXPRESSION; GENE EXPRESSION REGULATION; IN SITU HYBRIDIZATION; MALE; MESENCEPHALON; NERVE CELL PLASTICITY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; RECEPTOR DENSITY;

EID: 0035071145     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.2000.7590     Document Type: Article

References (42)

1. A receptors: Classification on the basis of subunit structure and receptor function
2. Reversal of experimental parkinsonism by lesions of the subthalamic nucleus
3. Expression of glutamate receptors in the human and rat basal ganglia: Effect of the dopaminergic denervation on AMPA receptor gene expression in the striatopallidal complex in Parkinson's disease and rat with 6-OHDA lesion
4. Glutamate and Parkinson's disease
5. Survival, growth and function of dopaminergic neurons grafted to the brain
6. Electrophysiology of dopamine-denervated striatal neurons: Implication for Parkinson's disease
7. Methods for determining numbers of cells and synapses: A case for more uniform standards of review
8. Behavioral and neurochemical recovery from partial 6-hydroxydopamine lesions of the substantia nigra is blocked by daily treatment with glutamate receptor antagonists MK-801 and CPP
9. A receptor subtypes during postnatal development: An immunohistochemical study
10. Regional changes of striatal dopamine receptors following denervation by 6-hydroxydopamine and fetal mesencephalic grafts in the rat
11. 3H]funitrazepam
12. GABA receptor agonist promotes reformation of the striatonigral pathway by transplant derived from fetal striatal primordia in the lesioned striatum
13. A detailed anatomical analysis of neurotransmitter receptors in the putamen and caudate in Parkinson's disease and Alzheimer's disease
14. Influence of dopamine on GABA release in striatum: Evidence for D1-D2 interactions and non-synaptic influences
15. NMDA antagonists potentiate antiparkinsonian actions of L-DOPA in monoamine-depleted rats
16. Dopamine/glutamate interactions in Parkinson's disease
17. Neural transplantation in Parkinson's disease
18. A receptor subtypes really occur in the brain?
19. Dopaminergic innervation of substance P-containing striatal neurons by fetal nigral grafts: An ultrastructural double-labeling immunocytochemical study
20. Apomorphine responses in Parkinson's disease and the pathogenesis of motor complications
21. Molecular biology of glutamate receptors in the central nervous system and their role in excitotoxicity, oxidative stress and aging
22. A receptors in rat neostriatum, cortex and thalamus after neonatal 6-hydroxydopamine lesion
23. γ-aminobutyric acid and benzodiazepine receptor changes induced by unilateral 6-hydroxydopamine lesions of the medial forebrain bundle
24. Polysynaptic regulation of glutamate receptors and mitochondrial enzyme activities in the basal ganglia of rats with unilateral dopamine depletion
25. Dopamine D1 receptor modulation of glutamate receptor messenger RNA levels in the neocortex and neostriatum of unilaterally 6-hydroxydopamine-lesioned rats
26. 2 receptor densities caused by 6-hydroxydopamine lesion of the nigrostriatal pathway in rats: An autoradiographic study
27. Mitochondria in the etiology and pathogenesis of Parkinson's disease
28. 14C]2-deoxy-D-glucose autoradiography
29. Effect ofdopaminergic denervation and transplant-derived reinnervation on a marker of striatal GABAergic function
30. Transplants of fetal substantia nigra regulate glutamic acid decarboxylase gene expression in host striatal neurons
31. Parallel increases in striatal glutamic acid decarboxylase activity and mRNA levels in rats with lesions of the nigrostriatal pathway
32. A receptor balance by functional mesencephalic dopaminergic grafts in mice with hereditary Parkinsonism
33. Localization of mGluR1a-like immunoreactivity and mGluR5-like immunoreactivity in identified populations of striatal neurons
34. Metabotropic glutamate receptor mRNA expression in the basal ganglia of the rat
35. Extracellular levels of amino acids in striatum and globus pallidus of 6-hydroxydopamine-lesioned rats measured with microdialysis
36. Effect of 6-OHDA lesions on striatal mRNA levels encoding for glutamate receptor subunits
37. Selective increase of NMDA-sensitive glutamate binding in the striatum of Parkinson's disease, Alzheimer's disease and mixed Parkinson's disease/Alzheimer's disease patients: An autoradiographic study
38. Glutamate receptors in striatum and substantia nigra: Effects of medial forebrain bundle lesions
39. A receptor subunit mRNA in the rat brain. I. Telecephalon, diencephalon, mesencephalon
40. A)/benzodiazepine receptor in the avian brain during development
41. A receptor in the hippocampus: Differential responses of CA1 and CA3